Welcome to the Kids' Library!

FDA drug approval : application review times largely reflect FDA goals : report to congressional req

United States. Government Accountability Office, author.
[Washington, D.C.] : United States Government Accountability Office, 2020. 2020

FY ... performance report to Congress for the Prescription Drug User Fee Act of 1992 as amended by t

[Washington, D.C.] : Food and Drug Administration, Dept. of Health and Human Services, [1998-2002] 2002

PDUFA pilot project proprietary name review.

[Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research, 2008] 2008

PDUFA V medical innovation, jobs, and patients : hearing before the Subcommittee on Health of the Co

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health.
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2012. 2012

The Prescription Drug User Fee Act : history through the 2007 PDUFA IV reauthorization

Thaul, Susan, author.
[Washington, D.C.] : Congressional Research Service, 2020- 2020

Prescription Drug User Fee Act (PDUFA): 2012 reauthorization as PDUFA V

Thaul, Susan, author.
[Washington, D.C.] : Congressional Research Service, 2019- 2019

The Prescription Drug User Fee Act : structure and reauthorization issues

Vogt, Donna U., author.
[Washington, D.C.] : Congressional Research Service, 2020- 2020

Prescription drugs FDA has met most performance goals for reviewing applications : report to congres

United States. Government Accountability Office.
[Washington, D.C.] : U.S. Govt. Accountability Office, [2012] 2012

Reauthorization of PDUFA what it means for jobs, innovation, and patients : hearing before the Subco

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health, author.
Washington : U.S. Government Printing Office, 2012. 2012